Fu, Jianing http://orcid.org/0000-0002-9348-2373
Schroder, Kate http://orcid.org/0000-0001-9261-3805
Article History
Accepted: 17 January 2024
First Online: 19 February 2024
Competing interests
: H.W. is a co-founder and chair of the Scientific Advisory Board of Ventus Therapeutics. K.S. is a co-inventor on patent applications for NLRP3 inhibitors that have been licensed to Inflazome Ltd, which was acquired by Roche. K.S. served on the Scientific Advisory Board of Inflazome, Ireland, and Quench Bio, USA, and serves on a Scientific Advisory Board for Novartis, Switzerland. J.F. declares no competing interests.